Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons

American Journal of Sports Medicine

Volumn 42, Issue 1, 2014, Pages 42-49

  Boswell, Stacie G ^a   Schnabel, Lauren V ^b   Mohammed, Hussni O ^b   Sundman, Emily A ^b   Minas, Tom ^c   Fortier, Lisa A ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Cornell University ^*  (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

growth factor; platelet; platelet rich plasma; tendon

Indexed keywords

COLLAGEN; COLLAGENASE 3; GROWTH FACTOR; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; HORSE; LEUKOCYTE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TENDINITIS; TENDON; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

GROWTH FACTOR; PLATELET; PLATELET-RICH PLASMA; TENDON;

ANIMALS; BLOOD PLATELETS; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HORSES; INTERLEUKIN-1BETA; LEUKOCYTES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; PLATELET-RICH PLASMA; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; TENDINOPATHY; TENDONS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892563086     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546513507566     Document Type: Article

References (38)

1. Anitua E, Sanchez M, Nurden AT, et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006 ; 24 (5). 227-234
2. Anitua E, Sanchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009 ; 42 (2). 162-170
3. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009 ; 23 (4). 177-189
4. Boswell SG, Cole BJ, Sundman EA, et al. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012 ; 28 (3). 429-439
5. Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011 ; 39 (2). 266-271
6. Creaney L, Wallace A, Curtis M, et al. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011 ; 45 (12). 966-971
7. de Mos M, van der Windt AE, Jahr H, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008 ; 36 (6). 1171-1178
8. Dohan Ehrenfest DM, Bielecki T, Del Corso MD, et al. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A. 2010 ; 95 (4). 1280-1282
9. Dohan Ehrenfest DM, Bielecki T, Jimbo R, et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2012 ; 13 (7). 1145-1152
10. Dragoo JL, Braun HJ, Durham JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012 ; 40 (6). 1274-1281
11. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003 ; 5 (14). 1317-1327
12. Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009 ; 37 (11). 2259-2272
13. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005 ; 84 (5). 434-439
14. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med. 2010 ; 31 (8). 577-583
15. Gosens T, Peerbooms JC, van Laar W, et al. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011 ; 39 (6). 1200-1208
16. Hechtman KS, Uribe JW, Botto-vanDemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics. 2011 ; 34 (2). 92
17. Jo CH, Kim JE, Yoon KS, et al. Platelet-rich plasma stimulates cell proliferation and enhances matrix gene expression and synthesis in tenocytes from human rotator cuff tendons with degenerative tears. Am J Sports Med. 2012 ; 40 (5). 1035-1045
18. Leitner GC, Gruber R, Neumuller J, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. 2006 ; 91 (2). 135-139
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 ; 25 (4). 402-408
20. Markopoulou CE, Markopoulos P, Dereka XE, et al. Effect of homologous PRP on proliferation of human periodontally affected osteoblasts: in vitro preliminary study. Report of a case. J Musculoskelet Neuronal Interact. 2009 ; 9 (3). 167-172
21. Mastrangelo AN, Vavken P, Fleming BC, et al. Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. J Orthop Res. 2011 ; 29 (7). 1002-1007
22. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med. 2012 ; 40 (8). 1742-1749
23. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009 ; 27 (8). 1033-1042
24. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012 ; 94 (19). e143
25. McLellan J, Plevin S. Does it matter which platelet-rich plasma we use?. Equine Vet Educ. 2011 ; 23 (2). 101-104
26. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 ; 34 (11). 1774-1778
27. Pillitteri D, Bassus S, Boller K, et al. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets. 2007 ; 18 (2). 119-127
28. Radice F, Yanez R, Gutierrez V, et al. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy. 2010 ; 26 (1). 50-57
29. Rodeo SA, Delos D, Williams RJ, et al. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am J Sports Med. 2012 ; 40 (6). 1234-1241
30. Sanchez M, Anitua E, Azofra J, et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007 ; 35 (2). 245-251
31. Sanchez M, Anitua E, Azofra J, et al. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy. 2010 ; 26 (4). 470-480
32. Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007 ; 25 (2). 230-240
33. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011 ; 39 (10). 2135-2140
34. Torricelli P, Fini M, Filardo G, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. 2011 ; 35 (10). 1569-1576
35. Trindade-Suedam IK, Leite FR, de Morais JA, et al. Avoiding leukocyte contamination and early platelet activation in platelet-rich plasma. J Oral Implantol. 2007 ; 33 (6). 334-339
36. Weibrich G, Kleis WK, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003 ; 14 (3). 357-362
37. Weibrich G, Kleis WK, Streckbein P, et al. Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma). Int J Oral Maxillofac Implants. 2012 ; 27 (4). 762-769
38. Yoshida R, Murray MM. Peripheral blood mononuclear cells enhance the anabolic effects of platelet-rich plasma on anterior cruciate ligament fibroblasts. J Orthop Res. 2013 ; 31 (1). 29-34